MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, TPST made $86K in revenue. -$3,511K in net income. Net profit margin of -4082.56%.

Income Overview

Revenue
$86K
Net Income
-$3,511K
Net Profit Margin
-4082.56%
EPS
-$0.79
Unit: Thousand (K) dollars
Revenue Breakdown
    • Interest income and other income...

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
Research and development
570 3,871
General and administrative
3,027 4,095
Loss from operations
-3,597 -7,966
Interest expense
0 46
Interest income and other income (expense), net
86 142
Total other income (expense), net
86 96
Provision for income taxes
0 0
Net loss
-3,511 -7,870
Net loss per share of common stock, rsus and pre-funded warrants, basic
-0.79 -2.07
Net loss per share of common stock, rsus and pre-funded warrants, diluted
-0.79 -2.07
Weighted-average shares of common stock, rsus and pre-funded warrants outstanding, basic
4,440,111 3,802,956
Weighted-average shares of common stock, rsus and pre-funded warrants outstanding, diluted
4,440,111 3,802,956
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income and otherincome (expense), net$86K Net loss-$3,511K Total other income(expense), net$86K Loss from operations-$3,597K General andadministrative$3,027K Research and development$570K

Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics, Inc. (TPST)